世界の血圧障害薬市場2022-2026

【英語タイトル】Global Blood Pressure Disorders Drug Market Research Report 2022-2026

9Dimen Researchが出版した調査資料(DMN22OT2058)・商品コード:DMN22OT2058
・発行会社(調査会社):9Dimen Research
・発行日:2022年10月
・ページ数:169
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,200 ⇒換算¥473,600見積依頼/購入/質問フォーム
Global/Corporate User(法人閲覧用)USD5,800 ⇒換算¥858,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

米中貿易戦争、世界経済の不安定性と不確実性は世界の血圧障害薬市場に大きな影響を与えるでしょう。血圧障害薬市場レポートは、主要地域(北アメリカ、ヨーロッパ、アジア太平洋)と主要国(アメリカ、ドイツ、英国、日本、韓国、中国)に焦点を当てた、世界の主要地域の市場状況に関する専門的かつ包括的な調査レポートです。このレポートでは、世界の血圧障害薬市場規模は 2022年にXX百万ドルと評価され、2026年末までにXX百万ドルに達すると予測されており、2022年から2026年にかけてXX%のCAGRで成長すると予測されています。
本調査レポートに記載されている主要な企業は、A1M Pharma AB、Acceleron Pharma Inc、Ache Laboratorios Farmaceuticos SA、Actelion Pharmaceuticals Ltd、Aerogen Ltd、Anavex Life Sciences Corp、AnGes Inc、Arena Pharmaceuticals Inc、Ascendia Pharmaceuticals LLC、Ascendis Pharma A/S、AVEO Pharmaceuticals Inc、Bayer AG、Bial - Portela & Ca SA、Bioblue Technologies Inc、Biogen Inc、Biolab Farmaceutica Ltda、BioRestorative Therapies Inc、Boryung Pharmaceutical Co Ltd、Bristol-Myers Squibb Co、Camurus AB、Capricor Therapeutics Inc、Celsion Corp、Celtaxsys Inc、Chiesi Farmaceutici SpA、Chong Kun Dang Pharmaceutical Corp、Chugai Pharmaceutical Co Ltd、CJ HealthCare Corp、Complexa Inc、Corion Biotech Srl、……などです。

本レポートは、世界の血圧障害薬市場(2022年-2026年)について調査・分析し、血圧障害薬の世界市場規模、市場予測、市場動向、上流市場分析、下流市場分析、アジア市場動向、北アメリカ市場動向、ヨーロッパ市場動向、マーケティングチャネル分析、投資可能性分析、メーカー分析などの情報を掲載しています。また、種類別(利尿薬、アンジオテンシン変換酵素(ACE)阻害薬、アンジオテンシン受容体遮断薬(ARB)、……など)、用途別(高血圧、低血圧、肺高血圧症、……など)のセグメント情報も収録しています。

・血圧障害薬の市場概要
・血圧障害薬の上流・下流市場分析
・血圧障害薬のアジア市場:市場分析(製品開発、競争環境、市場動向等)
・血圧障害薬のアジア市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬のアジア市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・血圧障害薬のアジア市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬の北アメリカ市場:市場分析(製品開発、競争環境、市場動向等)
・血圧障害薬の北アメリカ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬の北アメリカ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・血圧障害薬の北アメリカ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬のヨーロッパ市場:市場分析(製品開発、競争環境、市場動向等)
・血圧障害薬のヨーロッパ市場:市場規模(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬のヨーロッパ市場:主要メーカー分析(製品、用途、生産量、価格、企業連絡先等)
・血圧障害薬のヨーロッパ市場:市場予測(生産規模、市場シェア、需要、輸出・輸入等)
・血圧障害薬のマーケティングチャネル分析
・マクロ経済分析(中国経済、ヨーロッパ経済、アメリカ経済、日本経済、グローバル経済)
・血圧障害薬の投資可能性分析
・血圧障害薬の世界市場規模(2017年-2022年推移、2022年-2026年予測)
...

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Blood Pressure Disorders Drug Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Blood Pressure Disorders Drug market is valued at USD XX million in 2022 and is projected to reach USD XX million by the end of 2026, growing at a CAGR of XX% during the period 2022 to 2026.

The report firstly introduced the Blood Pressure Disorders Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial – Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl
……

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
……

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Blood Pressure Disorders Drug for each application, including-
Hypertension
Hypotension
Pulmonary Hypertension
……

❖ レポートの目次 ❖

Table of Contents

Part I Blood Pressure Disorders Drug Industry Overview

Chapter One Blood Pressure Disorders Drug Industry Overview
1.1 Blood Pressure Disorders Drug Definition
1.2 Blood Pressure Disorders Drug Classification Analysis
1.2.1 Blood Pressure Disorders Drug Main Classification Analysis
1.2.2 Blood Pressure Disorders Drug Main Classification Share Analysis
1.3 Blood Pressure Disorders Drug Application Analysis
1.3.1 Blood Pressure Disorders Drug Main Application Analysis
1.3.2 Blood Pressure Disorders Drug Main Application Share Analysis
1.4 Blood Pressure Disorders Drug Industry Chain Structure Analysis
1.5 Blood Pressure Disorders Drug Industry Development Overview
1.5.1 Blood Pressure Disorders Drug Product History Development Overview
1.5.1 Blood Pressure Disorders Drug Product Market Development Overview
1.6 Blood Pressure Disorders Drug Global Market Comparison Analysis
1.6.1 Blood Pressure Disorders Drug Global Import Market Analysis
1.6.2 Blood Pressure Disorders Drug Global Export Market Analysis
1.6.3 Blood Pressure Disorders Drug Global Main Region Market Analysis
1.6.4 Blood Pressure Disorders Drug Global Market Comparison Analysis
1.6.5 Blood Pressure Disorders Drug Global Market Development Trend Analysis

Chapter Two Blood Pressure Disorders Drug Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Blood Pressure Disorders Drug Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Blood Pressure Disorders Drug Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Blood Pressure Disorders Drug Market Analysis
3.1 Asia Blood Pressure Disorders Drug Product Development History
3.2 Asia Blood Pressure Disorders Drug Competitive Landscape Analysis
3.3 Asia Blood Pressure Disorders Drug Market Development Trend

Chapter Four 2017-2022 Asia Blood Pressure Disorders Drug Productions Supply Sales Demand Market Status and Forecast
4.1 2017-2022 Blood Pressure Disorders Drug Production Overview
4.2 2017-2022 Blood Pressure Disorders Drug Production Market Share Analysis
4.3 2017-2022 Blood Pressure Disorders Drug Demand Overview
4.4 2017-2022 Blood Pressure Disorders Drug Supply Demand and Shortage
4.5 2017-2022 Blood Pressure Disorders Drug Import Export Consumption
4.6 2017-2022 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Chapter Five Asia Blood Pressure Disorders Drug Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information


Chapter Six Asia Blood Pressure Disorders Drug Industry Development Trend
6.1 2022-2026 Blood Pressure Disorders Drug Production Overview
6.2 2022-2026 Blood Pressure Disorders Drug Production Market Share Analysis
6.3 2022-2026 Blood Pressure Disorders Drug Demand Overview
6.4 2022-2026 Blood Pressure Disorders Drug Supply Demand and Shortage
6.5 2022-2026 Blood Pressure Disorders Drug Import Export Consumption
6.6 2022-2026 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Part III North American Blood Pressure Disorders Drug Industry (The Report Company Including the Below Listed But Not All)

Chapter Seven North American Blood Pressure Disorders Drug Market Analysis
7.1 North American Blood Pressure Disorders Drug Product Development History
7.2 North American Blood Pressure Disorders Drug Competitive Landscape Analysis
7.3 North American Blood Pressure Disorders Drug Market Development Trend

Chapter Eight 2017-2022 North American Blood Pressure Disorders Drug Productions Supply Sales Demand Market Status and Forecast
8.1 2017-2022 Blood Pressure Disorders Drug Production Overview
8.2 2017-2022 Blood Pressure Disorders Drug Production Market Share Analysis
8.3 2017-2022 Blood Pressure Disorders Drug Demand Overview
8.4 2017-2022 Blood Pressure Disorders Drug Supply Demand and Shortage
8.5 2017-2022 Blood Pressure Disorders Drug Import Export Consumption
8.6 2017-2022 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Chapter Nine North American Blood Pressure Disorders Drug Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information


Chapter Ten North American Blood Pressure Disorders Drug Industry Development Trend
10.1 2022-2026 Blood Pressure Disorders Drug Production Overview
10.2 2022-2026 Blood Pressure Disorders Drug Production Market Share Analysis
10.3 2022-2026 Blood Pressure Disorders Drug Demand Overview
10.4 2022-2026 Blood Pressure Disorders Drug Supply Demand and Shortage
10.5 2022-2026 Blood Pressure Disorders Drug Import Export Consumption
10.6 2022-2026 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Part IV Europe Blood Pressure Disorders Drug Industry Analysis (The Report Company Including the Below Listed But Not All)

Chapter Eleven Europe Blood Pressure Disorders Drug Market Analysis
11.1 Europe Blood Pressure Disorders Drug Product Development History
11.2 Europe Blood Pressure Disorders Drug Competitive Landscape Analysis
11.3 Europe Blood Pressure Disorders Drug Market Development Trend

Chapter Twelve 2017-2022 Europe Blood Pressure Disorders Drug Productions Supply Sales Demand Market Status and Forecast
12.1 2017-2022 Blood Pressure Disorders Drug Production Overview
12.2 2017-2022 Blood Pressure Disorders Drug Production Market Share Analysis
12.3 2017-2022 Blood Pressure Disorders Drug Demand Overview
12.4 2017-2022 Blood Pressure Disorders Drug Supply Demand and Shortage
12.5 2017-2022 Blood Pressure Disorders Drug Import Export Consumption
12.6 2017-2022 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Chapter Thirteen Europe Blood Pressure Disorders Drug Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information


Chapter Fourteen Europe Blood Pressure Disorders Drug Industry Development Trend
14.1 2022-2026 Blood Pressure Disorders Drug Production Overview
14.2 2022-2026 Blood Pressure Disorders Drug Production Market Share Analysis
14.3 2022-2026 Blood Pressure Disorders Drug Demand Overview
14.4 2022-2026 Blood Pressure Disorders Drug Supply Demand and Shortage
14.5 2022-2026 Blood Pressure Disorders Drug Import Export Consumption
14.6 2022-2026 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Part V Blood Pressure Disorders Drug Marketing Channels and Investment Feasibility

Chapter Fifteen Blood Pressure Disorders Drug Marketing Channels Development Proposals Analysis
15.1 Blood Pressure Disorders Drug Marketing Channels Status
15.2 Blood Pressure Disorders Drug Marketing Channels Characteristic
15.3 Blood Pressure Disorders Drug Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals

Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis

Chapter Seventeen Blood Pressure Disorders Drug New Project Investment Feasibility Analysis
17.1 Blood Pressure Disorders Drug Market Analysis
17.2 Blood Pressure Disorders Drug Project SWOT Analysis
17.3 Blood Pressure Disorders Drug New Project Investment Feasibility Analysis

Part VI Global Blood Pressure Disorders Drug Industry Conclusions

Chapter Eighteen 2017-2022 Global Blood Pressure Disorders Drug Productions Supply Sales Demand Market Status and Forecast
18.1 2017-2022 Blood Pressure Disorders Drug Production Overview
18.2 2017-2022 Blood Pressure Disorders Drug Production Market Share Analysis
18.3 2017-2022 Blood Pressure Disorders Drug Demand Overview
18.4 2017-2022 Blood Pressure Disorders Drug Supply Demand and Shortage
18.5 2017-2022 Blood Pressure Disorders Drug Import Export Consumption
18.6 2017-2022 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Chapter Nineteen Global Blood Pressure Disorders Drug Industry Development Trend
19.1 2022-2026 Blood Pressure Disorders Drug Production Overview
19.2 2022-2026 Blood Pressure Disorders Drug Production Market Share Analysis
19.3 2022-2026 Blood Pressure Disorders Drug Demand Overview
19.4 2022-2026 Blood Pressure Disorders Drug Supply Demand and Shortage
19.5 2022-2026 Blood Pressure Disorders Drug Import Export Consumption
19.6 2022-2026 Blood Pressure Disorders Drug Cost Price Production Value Gross Margin

Chapter Twenty Global Blood Pressure Disorders Drug Industry Research Conclusions



★調査レポート[世界の血圧障害薬市場2022-2026] (コード:DMN22OT2058)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血圧障害薬市場2022-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆